Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer

Immunotherapy aiming to harness the exquisite power of the immune system has emerged as a crucial part of clinical cancer management. However, only a subset of cancer patients responds to current immunotherapy because of low immunogenicity of the tumor cells and immunosuppressive tumor microenvironm...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xianli, Hou, Bo, Xu, Zhiai, Saeed, Madiha, Sun, Fang, Gao, Zhenmei, Lai, Yi, Zhu, Tong, Zhang, Fan, Zhang, Wen, Yu, Haijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175291/
https://www.ncbi.nlm.nih.gov/pubmed/32328426
http://dx.doi.org/10.1002/advs.201903332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175291/
https://www.ncbi.nlm.nih.gov/pubmed/32328426
http://dx.doi.org/10.1002/advs.201903332

Ejemplares similares